title: Proton-decoupled myocardial 31P NMR spectroscopy reveals decreased PCr/Pi in patients with severe hypertrophic cardiomyopathy.
abstract: Disturbed myocardial energy metabolism may occur in patients with primary hypertrophic cardiomyopathy (HCM). A noninvasive way to gain insight into cardiac energy metabolism is provided by in vivo 31P nuclear magnetic resonance (NMR) spectroscopy. 31P NMR spectroscopy with proton decoupling was performed in 13 patients aged 13-36 years with HCM on a 1.5 T Magnetom with a double resonant surface coil. A 2D chemical shift imaging (CSI) sequence in combination with slice selective excitation was used to acquire spectra of the anteroseptal region of the left ventricle (volume element: 38 mL). The chemical shifts of the phosphorus metabolites, intracellular pHi, and coupling constants J(alphabeta) and J(gammabeta) were calculated. Peak areas of 2,3-diphosphoglycerate (DPG), Pi, and adenosine triphosphate (ATP) were determined and corrected for blood contamination, saturation, and differences in nuclear Overhauser enhancements (NOE). The maximum thickness of the interventricular septum (IVSmax) was determined from tomographic long-axis images and expressed as number of standard deviations above the mean of the normal population (Z score). The patients were then divided into 2 groups: 6 patients with moderate HCM (HCMm, Z score < or = 5) and 7 patients with severe HCM (HCMs, Z score > 5). No differences between both groups and a control group of healthy volunteers (n = 16) were found with respect to phosphocreatine (PCr)/gamma-ATP ratio, pHi, or the coupling constants. Only the PCr/Pi ratio differed significantly from the control group (HCM(all), alpha < 0.05, HCMs, alpha < 0.02, 2-sided U test). The decrease of the PCr/Pi ratio in patients with HCM is probably caused by ischemically decreased oxygen supply in the severely hypertrophied myocardium.
authors.affiliation: Department of Pediatric Cardiology, University of Tübingen, Germany.
authors.forename: L
authors.initials: L
authors.lastname: Sieverding
authors.forename: W I
authors.initials: WI
authors.lastname: Jung
authors.forename: J
authors.initials: J
authors.lastname: Breuer
authors.forename: S
authors.initials: S
authors.lastname: Widmaier
authors.forename: A
authors.initials: A
authors.lastname: Staubert
authors.forename: F
authors.initials: F
authors.lastname: van Erckelens
authors.forename: O
authors.initials: O
authors.lastname: Schmidt
authors.forename: M
authors.initials: M
authors.lastname: Bunse
authors.forename: T
authors.initials: T
authors.lastname: Hoess
authors.forename: O
authors.initials: O
authors.lastname: Lutz
authors.forename: G J
authors.initials: GJ
authors.lastname: Dietze
authors.forename: J
authors.initials: J
authors.lastname: Apitz
mesh_terms: D000255:Adenosine Triphosphate / Q000378:metabolism*; D000293:Adolescent; D000328:Adult; D002312:Cardiomyopathy, Hypertrophic / Q000378:metabolism*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008274:Magnesium / Q000378:metabolism*; D009682:Magnetic Resonance Spectroscopy / Q000379:methods*; D009206:Myocardium / Q000378:metabolism*; D010725:Phosphocreatine / Q000378:metabolism*; D010759:Phosphorus Isotopes; D011522:Protons
chemical_list: D010759:Phosphorus Isotopes; D011522:Protons; D010725:Phosphocreatine; D000255:Adenosine Triphosphate; D008274:Magnesium